Hexaware Positioned as a Visionary in the 2026 Gartner® Magic Quadrant™ for Custom Software Development Services
Hexaware Positioned as a Visionary in the 2026 Gartner® Magic Quadrant™ for Custom Software Development Services
Gartner, Magic Quadrant for Custom Software Development Services, By Jaideep Thyagarajan, Ryan McKinney, Nathan Davie, 7 October 2026. Gartner and Magic Quadrant are trademarks of Gartner, Inc. and/or its affiliates. Gartner does not endorse any company, vendor, product or service depicted in its publications, and does not advise technology users to select only those vendors with the highest ratings or other designation. Gartner publications consist of the opinions of Gartner’s business and technology insights organization and should not be construed as statements of fact. Gartner disclaims all warranties, expressed or implied, with respect to this publication, including any warranties of merchantability or fitness for a particular purpose. This graphic was published by Gartner, Inc. as part of a larger research document and should be evaluated in the context of the entire document. The Gartner document is available upon request from Hexaware.
Whitepaper
About this Content
AI is transforming pharmaceuticals, with generative AI leading the charge, offering human-like intelligence and reshaping customer engagement and sales optimization. This shift marks a transformative era in commercialization, offering profound insights and strategic opportunities.
This whitepaper explores the transformative potential of generative AI in the pharmaceutical industry’s commercialization landscape. It discusses the following:
Unlocking Gen AI’s full potential requires understanding, time, and the right technology partner. Leverage Hexaware’s expertise and Gen AI solutions for commercial excellence in pharmaceuticals. Download this whitepaper to learn more.
Get the Resource
Fill out the form below to gain instant access to our exclusive content.